Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Respiratory Investigation|August 6, 2025
Immune checkpoint inhibitor-related pneumonitis: From guidelines to the front linesMasato Karayama
Virus Research|November 26, 2008
Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latencyEriko Ohsaki, Tohru Suzuki, Masato Karayama, et al.
Chest|June 26, 2010
Antiendothelial Cell Antibodies in Patients With COPDMasato Karayama, Naoki Inui, Takafumi Suda, et al.
Biochemical and Biophysical Research Communications|February 24, 2010
KSHV-infected PEL cell lines exhibit a distinct gene expression profileKeiji Ueda, Emi Ito, Masato Karayama, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancerYasunori Enomoto, Naoki Inui, Terufumi Kato, et al.
Cancer Chemotherapy and Pharmacology|April 2, 2016
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancerMasato Karayama, Naoki Inui, Hideki Kusagaya, et al.
Cancer Chemotherapy and Pharmacology|July 3, 2015
Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung diseaseYasunori Enomoto, Naoki Inui, Shiro Imokawa, et al.
Investigational New Drugs|August 6, 2022
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumorsYoshito Komatsu, Tsuneo Shimokawa, Kohei Akiyoshi, et al.
European Journal of Clinical Pharmacology|August 19, 2021
Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patientsKazuki Abe, Kaito Shibata, Takafumi Naito, et al.
Respiratory Medicine Case Reports|March 9, 2017
Successful crizotinib monotherapy in <i>EGFR</i>-mutant lung adenocarcinoma with acquired <i>MET</i> amplification after erlotinib therapyKatsuhiro Yoshimura, Naoki Inui, Masato Karayama, et al.
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Respiratory Investigation|August 6, 2025
Immune checkpoint inhibitor-related pneumonitis: From guidelines to the front linesMasato Karayama
Virus Research|November 26, 2008
Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latencyEriko Ohsaki, Tohru Suzuki, Masato Karayama, et al.
Chest|June 26, 2010
Antiendothelial Cell Antibodies in Patients With COPDMasato Karayama, Naoki Inui, Takafumi Suda, et al.
Biochemical and Biophysical Research Communications|February 24, 2010
KSHV-infected PEL cell lines exhibit a distinct gene expression profileKeiji Ueda, Emi Ito, Masato Karayama, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancerYasunori Enomoto, Naoki Inui, Terufumi Kato, et al.
Cancer Chemotherapy and Pharmacology|April 2, 2016
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancerMasato Karayama, Naoki Inui, Hideki Kusagaya, et al.
Cancer Chemotherapy and Pharmacology|July 3, 2015
Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung diseaseYasunori Enomoto, Naoki Inui, Shiro Imokawa, et al.
Investigational New Drugs|August 6, 2022
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumorsYoshito Komatsu, Tsuneo Shimokawa, Kohei Akiyoshi, et al.
European Journal of Clinical Pharmacology|August 19, 2021
Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patientsKazuki Abe, Kaito Shibata, Takafumi Naito, et al.
Respiratory Medicine Case Reports|March 9, 2017
Successful crizotinib monotherapy in <i>EGFR</i>-mutant lung adenocarcinoma with acquired <i>MET</i> amplification after erlotinib therapyKatsuhiro Yoshimura, Naoki Inui, Masato Karayama, et al.
Pageof 20